Genomic and transcriptomic underpinnings of melanoma genesis, progression, and metastasis

OS Cherepakhin, ZB Argenyi, AS Moshiri - Cancers, 2021 - mdpi.com
Simple Summary Melanoma is a skin cancer with a high mortality and a dramatically rising
presence worldwide. Recent research has shed new light on the genetic events that …

Development of Personalized Strategies for Precisely Battling Malignant Melanoma

AJ Isaak, GGR Clements, RGM Buenaventura… - International Journal of …, 2024 - mdpi.com
Simple Summary Precision oncology is emerging as a viable option to improve survival in
patients who fail to remain disease-free even after the employment of currently available …

[HTML][HTML] Skp2 contributes to AKT activation by ubiquitination degradation of PHLPP1, impedes autophagy, and facilitates the survival of thyroid carcinoma

Y Shao, W Ren, H Dai, F Yang, X Li, S Zhang, J Liu… - Molecules and cells, 2023 - Elsevier
Papillary thyroid carcinoma (PTC) is the most common subtype of thyroid carcinoma.
Despite a good prognosis, approximately a quarter of PTC patients are likely to relapse …

Ultrasound molecular imaging-guided tumor gene therapy through dual-targeted cationic microbubbles

Y Liu, Y Zhou, J Xu, H Luo, Y Zhu, X Zeng… - Biomaterials …, 2021 - pubs.rsc.org
The success of gene therapy depends largely on the development of gene vectors and
effective gene delivery systems. It has been demonstrated that cationic microbubbles can be …

PTEN phosphatase inhibits metastasis by negatively regulating the Entpd5/IGF1R pathway through ATF6

Y Yu, M Dai, L Huang, W Chen, E Yu, A Mendoza… - Iscience, 2023 - cell.com
PTEN encodes a tumor suppressor with lipid and protein phosphatase activities whose
dysfunction has been implicated in melanomagenesis; less is known about how its …

PERK mediates resistance to BRAF inhibition in melanoma with impaired PTEN

Y Qin, Q Zuo, L Huang, L Huang, G Merlino… - NPJ Precision …, 2021 - nature.com
Targeting mutant BRAF in patients with melanomas harboring this oncogene has been
highly successful as a first-line treatment, but other mutations may affect its efficacy and alter …

AKT2 loss impairs BRAF-mutant melanoma metastasis

SK McRee, AL Bayer, J Pietruska, PN Tsichlis… - Cancers, 2023 - mdpi.com
Simple Summary Skin cancer, such as melanoma, is often treatable but becomes deadly
when it expands to other places in the body, a process called metastasis. While many …

AKT1 is required for a complete Palbociclib-Induced Senescence phenotype in BRAF-V600E-Driven Human Melanoma

AL Bayer, J Pietruska, J Farrell, S McRee, P Alcaide… - Cancers, 2022 - mdpi.com
Simple Summary One of the hallmarks of cancer is increased cellular proliferation; therefore,
many therapeutic strategies aim at arresting cellular division. Several chemotherapeutic …

[HTML][HTML] Emerging roles of PHLPP phosphatases in metabolism

JH Cha, Y Jeong, AR Oh, SB Lee, SS Hong, KJ Kim - BMB reports, 2021 - ncbi.nlm.nih.gov
Over the last decades, research has focused on the role of pleckstrin homology (PH) domain
leucine-rich repeat protein phosphatases (PHLPPs) in regulating cellular signaling via …

miR-141 Promotes Colon Cancer Cell Proliferation by Targeted PHLPP2 Expression Inhibitionn

F Fang, L Cheng, X Wu, M Ye… - Cancer Management and …, 2020 - Taylor & Francis
Objective Colon cancer (CC) is the third most common cancer with a high rate of incidence
and mortality. Therefore, it is highly necessary to explore novel targets of CC. Methods The …